Breaking News Instant updates and real-time market news.

LOXO

Loxo Oncology

$147.40

3.71 (2.58%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25

Loxo Oncology management to meet with Morgan Stanley

Group Luncheon Meeting with Chief Business Officer van Naarden, where 1:1s will be available as well, will be held in Boston on November 15 hosted by Morgan Stanley.

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

LOXO Loxo Oncology
$147.40

3.71 (2.58%)

10/08/18
IFSG
10/08/18
UPGRADE
IFSG
Outperform
Loxo Oncology upgraded to Outperform from Market Perform at IFS Securities
10/08/18
10/08/18
UPGRADE
Target $190

Outperform
Loxo Oncology upgraded to Outperform on LOXO-292 update at IFS Securities
As previously reported, IFS Securities analyst David Bouchey upgraded Loxo Oncology to Outperform from Market Perform, with $190 price target, after the company reported updated results from its Phase I/II trial for LOXO-292. The analyst believes the response rates for LOXO-292 continue to look "very strong," the safety data is "excellent" and early results show that these responses appear durable. So far, the drug has outperformed expectations, he adds.
10/22/18
PIPR
10/22/18
NO CHANGE
Target $200
PIPR
Overweight
Loxo 'highly likely' to win FDA approval next month, says Piper Jaffray
Loxo Oncology (LOXO) this weekend reported updated durability data for the original 55 TRK fusion patients treated with larotrectinib plus initial efficacy data from 54 newly-evaluable patients, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. He points out that the new patient dataset displayed a nearly identical response rate and that duration is tracking similarly with three quarters of patients maintaining a response out to a year. The updated larotrectinib data compare well to Roche's (RHHBY) competing entrectinib and makes the drug "highly likely" to be approved on or by the November 26 FDA action date, contends Van Buren. He reiterates an Overweight rating on Loxo Oncology with a $200 price target.
11/14/18
RAJA
11/14/18
INITIATION
Target $235
RAJA
Strong Buy
Loxo Oncology initiated with a Strong Buy at Raymond James
Raymond James initiated Loxo Oncology with a Strong Buy and $235 price target.

TODAY'S FREE FLY STORIES

SASR

Sandy Spring Bancorp

$34.06

0.55 (1.64%)

08:04
04/23/19
04/23
08:04
04/23/19
08:04
Conference/Events
Sandy Spring Bancorp management to meet with Stephens »

Group Luncheon with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 13

    May

ET

Energy Transfer LP

$15.58

0.32 (2.10%)

08:03
04/23/19
04/23
08:03
04/23/19
08:03
Hot Stocks
Energy Transfer LP announces resumed operations at Mariner East 1 pipeline »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BOLD

Audentes Therapeutics

$39.53

0.65 (1.67%)

08:03
04/23/19
04/23
08:03
04/23/19
08:03
Hot Stocks
Audentes Therapeutics launches cGMP plasmid manufacturing facility »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

TROV

Trovagene

$3.29

-0.05 (-1.50%)

, ABBV

AbbVie

$78.10

0.54 (0.70%)

08:03
04/23/19
04/23
08:03
04/23/19
08:03
Hot Stocks
Trovagene announces preclinical data evaluating onvansertib with venetoclax »

Trovagene (TROV)…

TROV

Trovagene

$3.29

-0.05 (-1.50%)

ABBV

AbbVie

$78.10

0.54 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABCB

Ameris Bancorp

$34.77

-0.4 (-1.14%)

, LION

Fidelity Southern

$27.79

-0.29 (-1.03%)

08:02
04/23/19
04/23
08:02
04/23/19
08:02
Hot Stocks
Ameris Bancorp sees FY19 normalized ROTCE 17%-19% »

Ameris Bancorp (ABCB)…

ABCB

Ameris Bancorp

$34.77

-0.4 (-1.14%)

LION

Fidelity Southern

$27.79

-0.29 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 14

    May

NVTA

Invitae

$22.80

-0.065 (-0.28%)

, UNH

UnitedHealth

$227.14

5.4 (2.44%)

08:02
04/23/19
04/23
08:02
04/23/19
08:02
Recommendations
Invitae, UnitedHealth, NeoGenomics, LabCorp, Quest Diagnostics, Opko Health analyst commentary  »

UnitedHealth preferred…

NVTA

Invitae

$22.80

-0.065 (-0.28%)

UNH

UnitedHealth

$227.14

5.4 (2.44%)

NEO

NeoGenomics

$20.00

0.33 (1.68%)

LH

LabCorp

$144.26

-0.94 (-0.65%)

DGX

Quest Diagnostics

$85.17

-0.55 (-0.64%)

OPK

Opko Health

$2.33

-0.075 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 14

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 23

    Jun

  • 06

    Aug

  • 13

    Nov

FB

Facebook

$181.49

3.21 (1.80%)

08:00
04/23/19
04/23
08:00
04/23/19
08:00
Recommendations
Facebook analyst commentary at Credit Suisse »

Signs of potential value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

ZLAB

Zai Lab

$29.36

0.17 (0.58%)

07:59
04/23/19
04/23
07:59
04/23/19
07:59
Conference/Events
Zai Lab to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

LYFT

Lyft

$60.91

2.6 (4.46%)

07:58
04/23/19
04/23
07:58
04/23/19
07:58
Initiation
Lyft initiated  »

Lyft initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

CDNS

Cadence Design

$64.23

0.87 (1.37%)

07:57
04/23/19
04/23
07:57
04/23/19
07:57
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

WSO

Watsco

$150.99

-0.39 (-0.26%)

07:56
04/23/19
04/23
07:56
04/23/19
07:56
Conference/Events
Watsco management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

07:55
04/23/19
04/23
07:55
04/23/19
07:55
General news
U.S. chain store sales dropped 1.4% in the week ended April 20 »

U.S. chain store sales…

LII

Lennox

$267.77

-2.97 (-1.10%)

07:54
04/23/19
04/23
07:54
04/23/19
07:54
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 23

    May

  • 05

    Jun

  • 13

    Nov

PENN

Penn National

$21.28

0.055 (0.26%)

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Recommendations
Penn National analyst commentary  »

Penn National attractive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

SCRYY

Scor

$0.00

(0.00%)

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
Scor management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

AUTL

Autolus Therapeutics

$26.67

0.09 (0.34%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Hot Stocks
Autolus Therapeutics receives orphan drug designation for enriched T-cells »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

MDSO

Medidata

$90.30

11.44 (14.51%)

, DASTY

Dassault Systemes

$0.00

(0.00%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Downgrade
Medidata, Dassault Systemes rating change  »

Medidata downgraded to…

MDSO

Medidata

$90.30

11.44 (14.51%)

DASTY

Dassault Systemes

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 23

    Jun

AZRX

AzurRx BioPharma

$2.60

0.185 (7.68%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
AzurRx BioPharma surpasses 50% enrollment for Phase 2 OPTION study »

AzurRx BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HAL

Halliburton

$31.09

-0.03 (-0.10%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Recommendations
Halliburton analyst commentary at SunTrust »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 15

    May

  • 22

    May

  • 29

    May

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
JetBlue sees Q2 effective tax rate of approx. 25% »

JetBlue expects an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

ACHC

Acadia

$29.66

0.16 (0.54%)

07:49
04/23/19
04/23
07:49
04/23/19
07:49
Recommendations
Acadia analyst commentary  »

Citi opens 'Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

PAG

Penske Automotive

$44.64

-1.305 (-2.84%)

07:48
04/23/19
04/23
07:48
04/23/19
07:48
Conference/Events
Penske Automotive management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 09

    May

  • 14

    May

  • 15

    May

  • 28

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
JetBlue says 'on track' to hit 2018-2020 CASM CAGR goal of 0-1% growth »

Says executing on plan to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

JEC

Jacobs Engineering

$78.69

1.755 (2.28%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
Jacobs Engineering extends contract with Watercare »

Jacobs has secured a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.